Menu Search
Equities

Cannabix Technologies Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
8CT:FRA

Cannabix Technologies Inc

Actions
  • Price (EUR)0.338
  • Today's Change0.006 / 1.81%
  • Shares traded250.00
  • 1 Year change+3.05%
  • Beta1.7104
Data delayed at least 15 minutes, as of Feb 16 2026 07:17 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Cannabix Technologies Inc. is a developer of marijuana and alcohol breathalyzer technologies for workplaces, law enforcement and other settings. Breath testing for delta-9 tetrahydrocannabinol (THC) (the primary psychoactive ingredient in cannabis) focuses on marijuana use. It is engaged in developing novel wall-mounted alcohol screening devices targeted primarily for workplace settings. It develops contactless breath alcohol detection devices. Its products include Cannabix Marijuana Breath Test (MBT) and BreathLogix Alcohol Breathalyzer. Its breath testing consists of Cannabis Breath Testing and Workplace Alcohol Testing. MBT utilizes a handheld Breath Collection Unit to capture the breath sample into a Cannabix Breath Cartridge that is shipped for laboratory analysis. The BreathLogix alcohol screening product is an autonomous alcohol screening system that enables the screening of employees, contractors and visitors in industries, such as mining, construction, oil and gas, and others.

  • Revenue in CAD (TTM)123.04k
  • Net income in CAD-6.32m
  • Incorporated2011
  • Employees--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.